CARBAMAZEPINE
NDC 16571-680, CARBAMAZEPINE, tablet, extended release, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-680
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211623
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-680 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBAMAZEPINE100 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-680-01 | 16571068001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-680-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bf1590a0-68a7-45ed-817e-f97366f96ec4NADAC price for package 16571068001
GET /v1/drugs/nadac/16571068001
Use it
Look up 16571-680 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-680 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-680. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.